FN2 Earnings Intelligence
Encompass Health Corporation income statement (quarterly)
Encompass Health Corporation (EHC) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $95.8 | $99.1 | $48.7 | $110.5 | $107.7 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $1,455.4 | $1,457.7 | $1,477.5 | $1,586.6 | $1,597.4 |
| % Growth | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| Net Income | $151.5 | $142.1 | $126.5 | $194.5 | $153.9 |
| % Margin | 10.4% | 9.7% | 8.6% | 12.3% | 9.6% |
| Diluted EPS | $1.48 | $1.39 | $1.24 | $1.93 | $1.54 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | $288.6 | - | - | $313.1 | - |
| CapEx | $163.1 | - | - | $162.4 | - |
| Free Cash Flow | $125.5 | - | - | $150.7 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $1,455.4 | $1,457.7 | $1,477.5 | $1,586.6 | $1,597.4 |
| Gross Profit | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Net Income | $151.5 | $142.1 | $126.5 | $194.5 | $153.9 |
| Diluted EPS | $1.48 | $1.39 | $1.24 | $1.93 | $1.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $95.8 | $99.1 | $48.7 | $110.5 | $107.7 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $789.3 | $790.2 | $791.1 | $792.9 | $788.4 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $288.6 | - | - | $313.1 | - |
| Capital Expenditure | $163.1 | - | - | $162.4 | - |
| Free Cash Flow | $125.5 | - | - | $150.7 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 10.4% | 9.7% | 8.6% | 12.3% | 9.6% |
| FCF Margin | 8.6% | - | - | 9.5% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the EHC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.